View of Beneficiary outcomes of abciximab in COVID-19 patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.

Return to Article Details Beneficiary outcomes of abciximab in COVID-19 patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Download Download PDF